Company intelligence / Profile preview
Obagi
- Ownership
- Private
- Development stage
- Other
Overview
Obagi is a global, physician-dispensed skincare brand specializing in clinically proven topical treatments for hyperpigmentation, sun damage, aging, acne, and uneven skin tone. Its products—including prescription-strength formulations—are widely used in dermatology, plastic surgery, and aesthetic clinics, and are recognized for improving skin appearance and health through advanced delivery technologies and active ingredients such as hydroquinone, tretinoin, salicylic acid, benzoyl peroxide, and vitamin C.
- Therapeutic areas
- Dermatology
- Modalities
- Topical small moleculeCosmetic formulationMedical device (e.g., blue peel technology)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Obagi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Obagi.